ENVALITH
オリンパス株式会社 logo

OLYMPUS CORPORATION

7733Prime MarketPrecision Instruments

オリンパス株式会社 logo
OLYMPUS CORPORATION7733
Reference Indicators

Market Cap

19,531¥100M

P/E (Forecast)

17.1x

P/B

2.4x

Dividend Yield (Forecast)

1.71%

ROE

8.4%

EV/EBITDA

11.2x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
868,867881,923936,210997,3321,010,676
Cost of Sales
297,172285,074311,087313,635356,586
Gross Profit
571,695596,849625,123683,697654,090
SG&A Expenses
405,399420,547473,231495,654507,080
Operating Income
153,898186,60943,598162,46297,120
Pre-tax Income
149,873182,29435,854159,07093,994
Income Taxes
33,90344,3048,88141,27025,822
Net Income
115,742143,432242,566117,85568,172
EBITDA
218,513253,350109,538228,918164,336
Gross Margin
65.8%67.7%66.8%68.6%64.7%
Operating Margin
17.7%21.2%4.7%16.3%9.6%
ROA
8.5%9.5%15.8%8.2%4.4%
ROE
22.7%22.4%32.0%15.7%8.4%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
消化器内視鏡ソリューション697,359136,35919.6%
サージカルインターベンション313,109-14,986-4.8%
その他208-499-239.9%
消化器内視鏡ソリューション事業000.0%
サージカルインターベンション事業000.0%